Skip to main content
. 2016 Apr 11;16:10. doi: 10.1186/s40644-016-0065-5

Fig. 1.

Fig. 1

The potential for prognostic biomarkers to stratify care for patients with NSCLC. CT showing left upper lobe NSCLC at initial staging a. Based on current practice, the patient underwent surgery without adjuvant chemotherapy. CT performed 25 months later shows local recurrence b. A biomarker deployed at staging may have categorised the patient as high-risk for recurrence, implying a potential benefit from adjuvant chemotherapy